Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sharon J Diskin

Showing results (11-20 of 95) with videos related to

Pageof 10
Sort By:
Medrxiv : the Preprint Server for Health Sciences|August 12, 2025
Confounding factors affecting analysis of germline structural variants in pediatric solid tumorsPandurang Kolekar, Rebecca S Kaufman, Nadezhda V Terekhanova, et al.
Human Genetics|August 27, 2024
Integrative genomic analyses identify neuroblastoma risk genes involved in neuronal differentiationMatilde Tirelli, Ferdinando Bonfiglio, Sueva Cantalupo, et al.
Plos Genetics|August 29, 2007
Assessing the significance of conserved genomic aberrations using high resolution genomic microarraysMitchell Guttman, Carolyn Mies, Katarzyna Dudycz-Sulicz, et al.
Nucleic Acids Research|September 12, 2008
Adjustment of genomic waves in signal intensities from whole-genome SNP genotyping platformsSharon J Diskin, Mingyao Li, Cuiping Hou, et al.
Molecular Cancer Research : MCR|May 29, 2008
A functional screen identifies miR-34a as a candidate neuroblastoma tumor suppressor geneKristina A Cole, Edward F Attiyeh, Yael P Mosse, et al.
International Journal of Cancer|September 6, 2012
Mitogen-activated protein kinase (MEK/ERK) inhibition sensitizes cancer cells to centromere-associated protein E inhibitionPatrick A Mayes, Yan Y Degenhardt, Andrew Wood, et al.
Journal of Cellular and Molecular Medicine|July 2, 2017
The functional variant rs34330 of CDKN1B is associated with risk of neuroblastomaMario Capasso, Lee D McDaniel, Flora Cimmino, et al.
American Journal of Human Genetics|September 3, 2019
Germline 16p11.2 Microdeletion Predisposes to NeuroblastomaLaura E Egolf, Zalman Vaksman, Gonzalo Lopez, et al.
Biorxiv : the Preprint Server for Biology|June 19, 2024
IMMUNOTAR - Integrative prioritization of cell surface targets for cancer immunotherapyRawan Shraim, Brian Mooney, Karina L Conkrite, et al.
Journal of the National Cancer Institute|February 23, 2019
Differences in Genomic Profiles and Outcomes Between Thoracic and Adrenal NeuroblastomaDerek A Oldridge, Bao Truong, Douglas Russ, et al.
Pageof 10

Showing results (11-20 of 95) with videos related to

Sort By:
Pageof 10
Medrxiv : the Preprint Server for Health Sciences|August 12, 2025
Confounding factors affecting analysis of germline structural variants in pediatric solid tumorsPandurang Kolekar, Rebecca S Kaufman, Nadezhda V Terekhanova, et al.
Human Genetics|August 27, 2024
Integrative genomic analyses identify neuroblastoma risk genes involved in neuronal differentiationMatilde Tirelli, Ferdinando Bonfiglio, Sueva Cantalupo, et al.
Plos Genetics|August 29, 2007
Assessing the significance of conserved genomic aberrations using high resolution genomic microarraysMitchell Guttman, Carolyn Mies, Katarzyna Dudycz-Sulicz, et al.
Nucleic Acids Research|September 12, 2008
Adjustment of genomic waves in signal intensities from whole-genome SNP genotyping platformsSharon J Diskin, Mingyao Li, Cuiping Hou, et al.
Molecular Cancer Research : MCR|May 29, 2008
A functional screen identifies miR-34a as a candidate neuroblastoma tumor suppressor geneKristina A Cole, Edward F Attiyeh, Yael P Mosse, et al.
International Journal of Cancer|September 6, 2012
Mitogen-activated protein kinase (MEK/ERK) inhibition sensitizes cancer cells to centromere-associated protein E inhibitionPatrick A Mayes, Yan Y Degenhardt, Andrew Wood, et al.
Journal of Cellular and Molecular Medicine|July 2, 2017
The functional variant rs34330 of CDKN1B is associated with risk of neuroblastomaMario Capasso, Lee D McDaniel, Flora Cimmino, et al.
American Journal of Human Genetics|September 3, 2019
Germline 16p11.2 Microdeletion Predisposes to NeuroblastomaLaura E Egolf, Zalman Vaksman, Gonzalo Lopez, et al.
Biorxiv : the Preprint Server for Biology|June 19, 2024
IMMUNOTAR - Integrative prioritization of cell surface targets for cancer immunotherapyRawan Shraim, Brian Mooney, Karina L Conkrite, et al.
Journal of the National Cancer Institute|February 23, 2019
Differences in Genomic Profiles and Outcomes Between Thoracic and Adrenal NeuroblastomaDerek A Oldridge, Bao Truong, Douglas Russ, et al.
Pageof 10